Latest Breaking News On - Darren opland - Page 5 : comparemela.com

Axsome Therapeutics To Present At The Piper Sandler 35Th Annual Healthcare Conference

Axsome Therapeutics Presents Results of the ACCORD trial of AXS-05 in Alzheimer's Disease ... | Region

NEW YORK, Oct. 24, 2023 (GLOBE NEWSWIRE) Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders,

Axsome Therapeutics Appoints Dr. Sue Mahony to its Board of Directors

NEW YORK, Oct. 11, 2023 Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today announced.

Axsome Therapeutics to Report Third Quarter 2023 Financial Results on November 6

Axsome to host conference call and webcast on Monday, Nov. 6, 2023, at 8:00 a.m. Eastern TimeNEW YORK, Oct. 10, 2023 Axsome Therapeutics, Inc. , a biopharmaceutical company developing and.

Axsome Therapeutics Joins the National Alliance on Mental Illness and Others Advocating for the Importance of Mental Health on Mental Illness Awareness Week

NEW YORK, Oct. 02, 2023 Axsome Therapeutics, Inc. , a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system disorders, today announced.